CHPA and FDA in talks on OTC monograph fees

18 July 2016 - Deborah Wilkes

The US Consumer Healthcare Products Association (CHPA) is having "detailed talks" with the Food and Drug Administration (FDA) about a potential user-fee programme for OTC monograph drugs.